Detalhe da pesquisa
1.
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
Diabetes Obes Metab;
25(9): 2553-2560, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37246796
2.
Evaluating glucose-lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial.
Diabetes Obes Metab;
22(8): 1231-1242, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32100382
3.
Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100.
Diabetes Obes Metab;
21(11): 2413-2421, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31264764
4.
Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM).
Diabetes Obes Metab;
20(1): 148-156, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28671753
5.
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.
Cardiovasc Diabetol;
14: 116, 2015 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26338040
6.
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.
Lancet;
379(9833): 2270-8, 2012 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22683137
7.
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study.
Health Qual Life Outcomes;
11: 217, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24369764
8.
Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Diabetes Ther;
12(5): 1463-1474, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33837921
9.
Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review.
Diabetes Ther;
10(3): 805-833, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31020538
10.
Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes.
Diabetes Ther;
9(3): 1099-1111, 2018 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29644618
11.
Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
J Diabetes Sci Technol;
12(6): 1184-1191, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29893144
12.
Thyroid sialyltransferase mRNA level and activity are increased in Graves' disease.
Thyroid;
15(7): 645-52, 2005 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16053379
13.
[Hashimoto's encephalopathy. Case report and literature review]. / Encefalopatia Hashimoto. Opis przypadku i przeglad literatury.
Neurol Neurochir Pol;
38(1): 55-9, 2004.
Artigo
em Polonês
| MEDLINE
| ID: mdl-15049170
14.
Initiation and gradual intensification of premixed insulin lispro therapy versus Basal {+/-} mealtime insulin in patients with type 2 diabetes eating light breakfasts.
Diabetes Care;
37(2): 372-80, 2014 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24170763
15.
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE.
Diabetes Ther;
4(2): 285-308, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24018835
16.
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.
Clinicoecon Outcomes Res;
5: 355-67, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23874113
17.
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.
Diabetes Metab Syndr Obes;
6: 171-85, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23667315
18.
Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
Clin Ther;
34(6): 1301-13, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22608106
19.
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
Diabetes Ther;
3(1): 6, 2012 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22714818
20.
Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.
Clin Ther;
33(11): 1682-93, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22036246